Orchestra BioMed(OBIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OBIO Orchestra BioMed

Trading 12-18 10:58:53 EST

4.46

+0.16

+3.72%

High4.56	Low4.35	Vol18.87K
Open4.39	D1 Closing4.30	Amplitude5.00%
Mkt Cap251.83M	Tradable Cap142.82M	Total Shares56.46M
T/O83.90K	T/O Rate0.06%	Tradable Shares32.02M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"OBIO","market":"US","secType":"STK","nameCN":"Orchestra BioMed","latestPrice":4.46,"timestamp":1766073461025,"preClose":4.3,"halted":0,"volume":18869,"delay":0,"floatShares":32021754,"shares":56464731,"eps":-1.797915,"marketStatus":"Trading","change":0.16,"latestTime":"12-18 10:58:53 EST","open":4.39,"high":4.56,"low":4.345,"amount":83904.2615156,"amplitude":0.05,"askPrice":4.49,"askSize":500,"bidPrice":4.45,"bidSize":388,"shortable":3,"etf":0,"ttmEps":-1.797915,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766091600000},"marketStatusCode":2,"adr":0,"listingDate":1596513600000,"exchange":"NASDAQ","adjPreClose":4.3,"postHourTrading":{"tag":"盘后","latestPrice":4.3,"preClose":4.3,"latestTime":"16:10 EST","volume":3,"amount":12.9,"timestamp":1766005804810},"volumeRatio":0.587572,"impliedVol":0.4457,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/OBIO","defaultTab":"news","newsList":[{"id":"2590539316","title":"Orchestra BioMed Holdings Initiated at Buy by TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539316","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590539316?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:12","pubTimestamp":1765383120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2025 11:12 ET (16:12 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BK4566","COWN","BK4082","OBIO","BK4207","BK4585","TD"],"gpt_icon":0},{"id":"2590961581","title":"Orchestra Biomed Holdings Inc : TD Cowen Initiates Coverage With Buy Rating; Price Target $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2590961581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590961581?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:56","pubTimestamp":1765367778,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG0LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","OBIO"],"gpt_icon":0},{"id":"2589330297","title":"BRIEF-Orchestra BioMed Announces AVIM Therapy And Virtue SAB Program Presentations At ICI Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589330297","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589330297?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:27","pubTimestamp":1765196837,"startTime":"0","endTime":"0","summary":"BRIEF-Orchestra BioMed Announces AVIM Therapy And Virtue SAB Program Presentations At ICI MeetingDec 8 (Reuters) - Medtronic PLC MDT.N:ORCHESTRA BIOMED ANNOUNCES AVIM THERAPY AND VIRTUE SAB PROGRAM PR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUARBDY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1571399168.USD","LU2023251221.USD","BK4585","LU1989771016.USD","BK4082","LU1244550577.SGD","LU2089283258.USD","LU1506573853.SGD","LU1116320737.USD","LU2089984988.USD","LU1023059063.AUD","IE000M9KFDE8.USD","BK4533","IE00B3T34201.USD","IE00BFXG1179.USD","LU1983299246.USD","LU2028103732.USD","LU0211326755.USD","LU1244550494.USD","LU2271345857.HKD","LU1116320901.HKD","LU1244550221.USD","LU0070302665.USD","LU0162691827.USD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU0314106906.USD","LU0122379950.USD","LU1989764748.USD","LU0211326839.USD","LU0158827781.USD","LU1989764664.SGD","BK4566","LU0211331839.USD","LU2089284900.SGD","LU0072461881.USD","LU2111349929.HKD","MDT","IE00BQXX3D17.EUR","LU0432979614.USD","LU0265550359.USD","LU0208291251.USD","LU1057294990.SGD","LU0265550946.USD","LU2112291526.USD","LU1291159041.SGD","OBIO","LU0976567544.SGD","LU0158827948.USD"],"gpt_icon":0},{"id":"2589337262","title":"Orchestra BioMed Showcases AVIM Therapy and Virtue SAB at ICI Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589337262?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195213,"startTime":"0","endTime":"0","summary":"Orchestra BioMed Holdings Inc. participated in the 2025 Innovation in Cardiology Intervention  meeting in Tel Aviv, Israel, where the company delivered three presentations. These included two focused on Atrioventricular Interval Modulation Therapy  and its ongoing strategic collaboration with Medtronic for the treatment of uncontrolled hypertension in pacemaker patients, and one on the Virtue Sirolimus AngioInfusion Balloon , highlighting its novel drug delivery technology for coronary artery disease and updates from the Virtue IDE trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via GlobeNewswire  on December 08, 2025, and is solely res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL5GjKw8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU2023251221.USD","BK4585","LU1989771016.USD","BK4082","LU2089283258.USD","LU1506573853.SGD","LU1116320737.USD","LU2095319765.USD","LU2089984988.USD","LU2468319806.SGD","LU1023059063.AUD","BK4533","IE00B3T34201.USD","IE00BFXG1179.USD","IE00BGHQF748.EUR","LU1983299246.USD","LU2028103732.USD","LU0211326755.USD","BK4112","LU2271345857.HKD","SG9999014021.USD","LU1116320901.HKD","LU0070302665.USD","LU0162691827.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","LU0314106906.USD","NDAQ","LU1989764748.USD","LU0496365809.HKD","IE00BKPKM429.USD","LU1989764664.SGD","LU0158827781.USD","LU0211331839.USD","LU0314104364.USD","LU2089284900.SGD","LU2111349929.HKD","MDT","BK4588","LU0432979614.USD","LU0265550359.USD","LU0208291251.USD","LU1057294990.SGD","LU0320765489.SGD","LU0265550946.USD","LU1291159041.SGD","OBIO","LU0976567544.SGD","LU0158827948.USD"],"gpt_icon":0},{"id":"2589377653","title":"Orchestra Biomed Announces Avim Therapy and Virtue SAB Program Presentations at Ici Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589377653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589377653?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUARBDY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0070302665.USD","IE000M9KFDE8.USD","IE00BQXX3C00.GBP","LU0976567544.SGD","LU1116320737.USD","LU1989764664.SGD","LU2468319806.SGD","LU0158827781.USD","LU0158827948.USD","LU1244550221.USD","LU1571399168.USD","MDT","LU1244550577.SGD","LU2023251221.USD","LU1291159041.SGD","BK4566","BK4082","LU0265550946.USD","LU0314106906.USD","IE00BFXG1179.USD","IE00B3T34201.USD","LU0496365809.HKD","LU1116320901.HKD","LU2028103732.USD","LU1244550494.USD","LU0211326839.USD","LU1061106388.HKD","BK4588","OBIO","LU1983299246.USD","BK4533","LU0208291251.USD","LU1023059063.AUD","LU2112291526.USD","LU2111349929.HKD","LU0211326755.USD","LU0265550359.USD","LU0432979614.USD","LU2271345857.HKD","LU0320765489.SGD","LU1989764748.USD","LU2089984988.USD","LU1989771016.USD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU2089283258.USD","LU1057294990.SGD","LU1506573853.SGD","LU0162691827.USD","LU2089284900.SGD"],"gpt_icon":0},{"id":"2586026049","title":"BRIEF-Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586026049","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586026049?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:13","pubTimestamp":1764191592,"startTime":"0","endTime":"0","summary":"BRIEF-Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)Nov 26 (Reuters) - Orchestra Biomed Holdings Inc OBIO.O:ORCHESTRA BIOMED ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUA1YMMTV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","OBIO"],"gpt_icon":0},{"id":"2586226097","title":"Orchestra BioMed Grants Stock Options to New Hires Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2586226097","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586226097?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:05","pubTimestamp":1764191111,"startTime":"0","endTime":"0","summary":"Orchestra BioMed Holdings Inc. has granted stock options to purchase a total of 151,250 shares of common stock to 12 recently hired employees under its 2025 New Hire Inducement Plan. Under the terms of the plan, 25% of each employee's stock options will vest on the first anniversary of their employment start date, with the remaining options vesting quarterly over the subsequent three years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via GlobeNewswire  on November 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL6BzWcK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","OBIO","BK4082","LU0314104364.USD","BK4585","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","NDAQ","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112"],"gpt_icon":0},{"id":"2584219689","title":"Orchestra BioMed Q3 EPS USD -0.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2584219689","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584219689?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:15","pubTimestamp":1763572541,"startTime":"0","endTime":"0","summary":"Nov 10 (Reuters) - Orchestra BioMed Q3 net income USD -20.8 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 10-NOV-202521:11:23.82 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1tQfPt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","OBIO"],"gpt_icon":0},{"id":"2584409672","title":"Orchestra BioMed Director and Officer David P. Hochman Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584409672","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584409672?lang=en_us&edition=fundamental","pubTime":"2025-11-18 06:01","pubTimestamp":1763416862,"startTime":"0","endTime":"0","summary":"David P. Hochman, Director and Officer of Orchestra Biomed Holdings Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDLbF7fbb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Orchestra BioMed Director and Officer David P. Hochman Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBIO","BK4082"],"gpt_icon":0},{"id":"2583593524","title":"Orchestra BioMed Management Highlights Strategic Progress and $150 Million Financing in Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583593524","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583593524?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:33","pubTimestamp":1763040816,"startTime":"0","endTime":"0","summary":"Orchestra Biomed Holdings Inc. held a Third Quarter 2025 Corporate Update Conference Call on November 12, 2025. During the call, Chairman and CEO David Hochman highlighted the company's partnership-enabled business model and its focus on advancing high-impact medical device innovations. Orchestra BioMed's two main programs, AVIM Therapy and Virtue SAB, target unmet needs in hypertensive heart disease and artery disease, representing multi-billion dollar opportunities in interventional medicine. The management team emphasized their strategy of collaborating with global market leaders to accelerate product development and deliver value to patients, physicians, and shareholders. No URL for the full speech or interview is provided in the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL3nyDVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBIO","BK4082"],"gpt_icon":0},{"id":"2583303746","title":"Orchestra BioMed Holdings Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2583303746","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583303746?lang=en_us&edition=fundamental","pubTime":"2025-11-13 00:08","pubTimestamp":1762963680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 12, 2025 11:08 ET (16:08 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBIO"],"gpt_icon":0},{"id":"2582905327","title":"Orchestra Biomed Holdings, Inc. : Barclays Cuts Target Price to $11 From $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2582905327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582905327?lang=en_us&edition=fundamental","pubTime":"2025-11-12 18:49","pubTimestamp":1762944599,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nAZN4QQ2P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","OBIO"],"gpt_icon":0},{"id":"2582726321","title":"Barclays Sticks to Their Buy Rating for Orchestra BioMed Holdings (OBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582726321","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582726321?lang=en_us&edition=fundamental","pubTime":"2025-11-12 17:26","pubTimestamp":1762939591,"startTime":"0","endTime":"0","summary":"In a report released today, Matt Miksic from Barclays maintained a Buy rating on Orchestra BioMed Holdings, with a price target of $11.00. Miksic c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-their-buy-rating-for-orchestra-biomed-holdings-obio-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-their-buy-rating-for-orchestra-biomed-holdings-obio-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OBIO"],"gpt_icon":0},{"id":"2582362353","title":"Orchestra BioMed Holdings Inc. to Join Piper 37th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2582362353","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582362353?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:00","pubTimestamp":1762869617,"startTime":"0","endTime":"0","summary":"Orchestra Biomed Holdings Inc. will participate in the Piper 37th Annual Healthcare Conference in New York from December 2-4, 2025. The company will take part in a live fireside chat with Matthew O'Brien, Senior Research Analyst at Piper Sandler, at 11:00am ET on December 3, and will also host one-on-one meetings with investors. The event will be accessible via a live webcast on Orchestra BioMed's Investor Relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via GlobeNewswire  on November 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL6HXBMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","OBIO","IE00B3QW5Z07.USD","BK4082","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4585","BK4112","LU2095319765.USD"],"gpt_icon":0},{"id":"2582385534","title":"Orchestra BioMed reports Q3 EPS (40c), consensus (43c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385534?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:50","pubTimestamp":1762811417,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $861,000, consensus $747,600. Hochman stated: “The last several months have been a period of exceptional execution, during which...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/orchestra-biomed-reports-q3-eps-40c-consensus-43c-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/orchestra-biomed-reports-q3-eps-40c-consensus-43c-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OBIO"],"gpt_icon":0},{"id":"2582887013","title":"Orchestra BioMed Hldgs Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $861.000K Beat $757.600K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582887013","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582887013?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:32","pubTimestamp":1762810332,"startTime":"0","endTime":"0","summary":"Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 5.21 percent. This is a 2.44 percent increase over losses of $(0.41) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48767549/orchestra-biomed-hldgs-q3-eps-0-40-beats-0-42-estimate-sales-861-000k-beat-757-600k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Orchestra BioMed Hldgs Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $861.000K Beat $757.600K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBIO"],"gpt_icon":0},{"id":"2582469800","title":"BRIEF-Orchestra BioMed Q3 EPS USD -0.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2582469800","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582469800?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:11","pubTimestamp":1762809083,"startTime":"0","endTime":"0","summary":"BRIEF-Orchestra BioMed Q3 EPS USD -0.4\n\n\nNov 10 (Reuters) - Orchestra BioMed Q3 net income USD -20.8 million.\n\nQ3 revenue USD 900 thousand vs. IBES estimate USD 734.8 thousand","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLX90C82F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBIO","BK4082"],"gpt_icon":0},{"id":"2582800151","title":"Orchestra Biomed Q3 Net Income USD -20.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582800151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582800151?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:10","pubTimestamp":1762809038,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLX90C82F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","OBIO"],"gpt_icon":0},{"id":"2582580044","title":"Press Release: Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582580044","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582580044?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:10","pubTimestamp":1762809000,"startTime":"0","endTime":"0","summary":"-- Secured $147.6 million in proceeds and committed capital following. completion of strategic transactions and concurrent public and private. equity offerings, led by $71.6 million in committed capital from. Medtronic and Ligand, as well as $30 million from Terumo. -- Initiated patient enrollments in the Virtue Trial evaluating Virtue. -- Demonstrated partnership-driven business model execution with expanded. strategic collaboration with Medtronic and new right of first refusal. NEW HOPE, Pa., Nov. 10, 2025  -- Orchestra BioMed Holdings, Inc. , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the third quarter ended September 30, 2025, and provided a business update highlighting recent financial and regulatory milestones.-- Completed multiple strategic transactions and concurrent public and. private equity offerings totaling $147.6 million in gross proceeds to. support continued advan","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","IE000M9KFDE8.USD","IE00BQXX3C00.GBP","LU0158827781.USD","LU0158827948.USD","LU0162691827.USD","LU1506573853.SGD","TM","LU1116320737.USD","IE00BFXG1179.USD","IE00BQXX3F31.USD","MDT","LU2028103732.USD","IE00BQXX3D17.EUR","LU0320765489.SGD","LU2089283258.USD","LU0265550946.USD","LU1116320901.HKD","03160","LU0976567544.SGD","LU1571399168.USD","IE00B3T34201.USD","LU2112291526.USD","LU1983299246.USD","LU0208291251.USD","LU2089984988.USD","BK4232","BK4099","LU1057294990.SGD","LU1989764748.USD","LU2468319806.SGD","LU1989764664.SGD","BK4533","LU2089284900.SGD","LU0122379950.USD","LU1244550221.USD","R","BK4604","LU1061106388.HKD","OBIO","BK4588","LU0211326755.USD","LU0211326839.USD","LU0265550359.USD","LU0496365809.HKD","LU1023059063.AUD","BK4585","LU0070302665.USD","BK4555","LU1244550494.USD"],"gpt_icon":0},{"id":"2580213606","title":"Orchestra BioMed to Host Business Update Call on November 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580213606","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580213606?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:00","pubTimestamp":1762174800,"startTime":"0","endTime":"0","summary":"NEW HOPE, Pa., Nov.  03, 2025  (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179221/0/en/Orchestra-BioMed-to-Host-Business-Update-Call-on-November-12-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2111349929.HKD","LU1244550494.USD","LU0122379950.USD","LU1506573853.SGD","IE00B3T34201.USD","LU0265550359.USD","LU2089284900.SGD","LU0211326839.USD","LU1116320737.USD","LU1983299246.USD","BK4585","LU2023251221.USD","LU1057294990.SGD","IE00BFXG1179.USD","LU2468319806.SGD","LU0158827948.USD","LU1571399168.USD","LU0072461881.USD","LU0314106906.USD","HST","LU1116320901.HKD","LU0211326755.USD","LU0320765489.SGD","LU0070302665.USD","BK4588","LU1244550577.SGD","MDT","LU1291159041.SGD","LU0211331839.USD","IE00BQXX3F31.USD","LU1061106388.HKD","IE000M9KFDE8.USD","LU0208291251.USD","LU2271345857.HKD","LU1989764664.SGD","LU2028103732.USD","LU0158827781.USD","IE00BQXX3C00.GBP","LU1989771016.USD","LU1989764748.USD","OBIO","BK4218","LU0496365809.HKD","LU1023059063.AUD","LU0162691827.USD","IE00BQXX3D17.EUR","BK4566","BK4181","BK4533","LU2112291526.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://investors.orchestrabiomed.com","stockEarnings":[{"period":"1week","weight":-0.0792},{"period":"1month","weight":0.0412},{"period":"3month","weight":0.7131},{"period":"6month","weight":0.4286},{"period":"1year","weight":-0.1296},{"period":"ytd","weight":0.075}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.028224},{"month":2,"riseRate":0.6,"avgChangeRate":-0.013749},{"month":3,"riseRate":0.4,"avgChangeRate":0.145591},{"month":4,"riseRate":0.2,"avgChangeRate":-0.133279},{"month":5,"riseRate":0.4,"avgChangeRate":0.080585},{"month":6,"riseRate":0.4,"avgChangeRate":-0.08454},{"month":7,"riseRate":0.2,"avgChangeRate":-0.029112},{"month":8,"riseRate":0.2,"avgChangeRate":-0.031625},{"month":9,"riseRate":0.5,"avgChangeRate":0.011914},{"month":10,"riseRate":0.5,"avgChangeRate":0.019494},{"month":11,"riseRate":0.833333,"avgChangeRate":0.139351},{"month":12,"riseRate":0.666667,"avgChangeRate":0.019254}],"exchange":"NASDAQ","name":"Orchestra BioMed","nameEN":"Orchestra BioMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Orchestra BioMed(OBIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Orchestra BioMed(OBIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Orchestra BioMed,OBIO,Orchestra BioMed股票,Orchestra BioMed股票老虎,Orchestra BioMed股票老虎国际,Orchestra BioMed行情,Orchestra BioMed股票行情,Orchestra BioMed股价,Orchestra BioMed股市,Orchestra BioMed股票价格,Orchestra BioMed股票交易,Orchestra BioMed股票购买,Orchestra BioMed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Orchestra BioMed(OBIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Orchestra BioMed(OBIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}